Reyedar
PrivateLast Round
Grant
Jun 28, 2024
Total Funding Raised
$4.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reyedar operates in Healthcare & Life Sciences and is based in Groningen. Its latest recorded funding round was a Grant round in June 2024.
Reyedar is a healthtech company that develops AI-powered eye-tracking diagnostic tools for the early detection of degenerative retinal and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reyedar Comparables
Compare Reyedar with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bulbitech | 87% | |
| machineMD | 84% | |
| neuroClues | 83% |
For institutional investors. Book with your work email.
Reyedar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2024 | ||||
| Seed | Jul 5, 2023 | ||||
| Seed | Nov 5, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reyedar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blue Sparrows MedTech Fund | Seed |
| University Medical Center Groningen | Grant |
| Cottonwood Technology Fund | Seed |
| UNETI | Seed |
| NOM (Investment and Development Company for the Northern Netherlands) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 4420% MoM, reaching 904.
- Nov 25, 2025
Added Glenn Mullin from Academia/Research as a customer.
For institutional investors. Book with your work email.
Reyedar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reyedar's valuation, stock price, and market status.
Is Reyedar a public or private company?
Reyedar is a private company.
What is the current stock price of Reyedar?
Reyedar is a private company, so its shares have no public market price. Caplight tracks Reyedar's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reyedar worth (valuation)?
Valuation information for Reyedar is not publicly available.
Can I buy Reyedar stock?
Reyedar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reyedar's last funding round?
Reyedar's most recent funding round was Grant on June 28, 2024.
Who are the main investors in Reyedar?
Key investors in Reyedar include Blue Sparrows MedTech Fund, Cottonwood Technology Fund.
Will Reyedar IPO soon?
No public IPO plans have been announced for Reyedar.
How can I track Reyedar secondary market activity?
Caplight tracks bids, offers, and trades in Reyedar's shares on secondary markets.